Zimmer Biomet Holdings, INC Form 4 insider transactions

Chad F. Phipps, Senior Vice President at Zimmer Biomet, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Zimmer Biomet's Group President, Asia Pacific, Sang Yi, acquired 2,785 shares of common stock through the vesting of Restricted Stock Units.

Zimmer Biomet Holdings, Inc.'s SVP and CHRO, Lori Winkler, reported the vesting of restricted stock units and subsequent share transactions for tax obligations.

Zimmer Biomet Holdings, Inc. CFO Suketu Upadhyay reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Zimmer Biomet Holdings, Inc. CEO Ivan Tornos reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Paul A. Stellato, VP, Controller, and CAO of Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent share disposition for tax obligations.

Zimmer Biomet Holdings, Inc. granted 10,076 Restricted Stock Units to Senior Vice President, Chief Strategy, Innovation & Business Development Officer Jehanzeb Noor, vesting over three years.

Chad F. Phipps, a Senior VP at Zimmer Biomet, reported the vesting of restricted stock units and a new RSU grant, alongside shares withheld for tax obligations.

Zimmer Biomet Holdings, Inc. Group President Kevin R. Thornal was granted 27,385 Restricted Stock Units, vesting over three years.

Zimmer Biomet's Group President, Asia Pacific, Sang Yi, acquired common stock through RSU conversion and received new RSU grants.

Zimmer Biomet's Group President, EMEA, Wilfred Van Zuilen, reported the vesting of restricted stock units, subsequent tax withholding, and a new RSU grant.

Zimmer Biomet Holdings SVP and CHRO Lori Winkler reported the vesting of restricted stock units, subsequent tax-related share disposal, and the grant of new RSUs.

Zimmer Biomet Holdings, Inc.'s VP, Controller, and CAO, Paul A. Stellato, reported the vesting of restricted stock units, acquisition of common stock, and new RSU grants.

Zimmer Biomet Holdings, Inc.'s Chairman, President, and CEO, Ivan Tornos, reported the exercise of restricted stock units, subsequent tax withholding, and the grant of new restricted stock units.

Zimmer Biomet's CFO, Suketu Upadhyay, reported the vesting and tax-related disposition of restricted stock units, alongside the acquisition of new RSUs.

Zimmer Biomet Holdings' SVP and CHRO, Lori Winkler, earned 3,935 performance-based Restricted Stock Units following the achievement of 2023-2025 performance targets.

Zimmer Biomet Holdings, Inc. officer Wilfred Van Zuilen earned 4,843 performance-based Restricted Stock Units, vesting on March 6, 2026.

Zimmer Biomet Holdings, Inc.'s Executive VP and CFO, Suketu Upadhyay, earned 10,217 performance-based Restricted Stock Units, which are set to vest on March 6, 2026.

Zimmer Biomet's VP, Controller, and CAO, Paul A. Stellato, earned 1,363 performance-based Restricted Stock Units following the 2023-2025 performance period, set to vest on March 6, 2026.

Chad F. Phipps, Sr. VP/Chief Legal Corporate Affairs & Secretary at Zimmer Biomet Holdings, Inc., earned 4,692 performance-based Restricted Stock Units.

Zimmer Biomet Holdings, Inc. Group President, Asia Pacific, Sang Yi, earned 7,050 performance-based Restricted Stock Units following the achievement of 2023-2025 performance targets.

Zimmer Biomet Holdings, Inc. Chairman, President, and CEO Ivan Tornos earned 24,436 performance-based Restricted Stock Units, vesting on March 6, 2026.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli reported the acquisition of 172.977 phantom stock units as part of her compensation plan.

Zimmer Biomet Holdings, Inc. Director Robert Hagemann acquired 304.439 phantom stock units under a deferred compensation plan.

Zimmer Biomet Holdings, Inc. Director Louis Shapiro acquired 152.22 phantom stock units, increasing his total beneficial ownership to 2,500.354 units.

Zimmer Biomet Holdings Director Arthur J. Higgins acquired 304.439 phantom stock units under a deferred compensation plan, increasing his total beneficial ownership to 35,967.099 units.

Zimmer Biomet Holdings Director Maria Teresa Hilado acquired 373.63 phantom stock units under a deferred compensation plan.

Zimmer Biomet Holdings Director Devdatt Kurdikar reported the acquisition of 152.22 phantom stock units, increasing his total beneficial ownership to 1,769.983 units.

Zimmer Biomet Director Michael J. Farrell acquired 415.144 phantom stock units, increasing his beneficial ownership to 17,775.682 units.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent share withholding for tax obligations.